Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;42:e3-
Published online before print June 23, 2003, doi: 10.1161/01.HYP.0000081965.51761.AA
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
42/2/e3    most recent
01.HYP.0000081965.51761.AAv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosmond, R.
Right arrow Articles by Wang, X. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosmond, R.
Right arrow Articles by Wang, X. L.

(Hypertension. 2003;42:e3.)
© 2003 American Heart Association, Inc.


Letters to the Editor

Glucocorticoid Receptor Gene and Coronary Artery Disease: Right Idea, Wrong Gene Variant?

Roland Rosmond

Department of Clinical Chemistry, Sahlgrenska University Hospital, Göteborg, Sweden


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

To the Editor:

Recent data reported by Lin et al1 suggest that coronary artery disease (CAD) is associated with an Asn363Ser variant in exon 2 of the glucocorticoid receptor gene (GRL). The study is based on the notion that a dysfunctional glucocorticoid receptor may add to the adverse health effects of excessive cortisol concentrations.

In a previous study, comprising Anglo-Celtic descent with a strong hereditability for hypertension and formerly designed to test the relationship between GRL and essential hypertension, the authors found an association between the Ser363 variant and elevated body mass index (BMI).2 However, no association or linkage with hypertension was detected.3 This lack of effect on blood pressure has been reported previously in a Dutch cohort.4

The authors fail to provide valuable pieces of information regarding previously published observations. The fact is that the only studies indicating an association between the Ser363 variant and obesity, measured as BMI, is that of Lin et al2 and Huizenga et al.4 In the referenced study of the Newcastle Heart Project,5 a significant association of the Ser allele was detected with increased waist-to-hip ratio (WHR) and not BMI in white men. To see an association with WHR in this report the authors needed to correct for a number of other factors that associate with central obesity, hence the multivariate approach (Christopher P.F. Redfern, personal communication, 2001). More importantly, however, is that a majority of studies indicates that the ATT to GTT point variation in exon 2 of the GRL is . . . [Full Text of this Article]

Brian J. Morris; Ruby C.Y. Lin

Basic & Clinical Genomics Laboratory, School of Medical Sciences, and Institute for Biomedical Research, The University of Sydney, Sydney, Australia

Xing Li Wang

Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, Cardiovascular Genetics Laboratory, Prince of Wales Hospital, Centre for Thrombosis and Vascular Research, University of New South Wales, Sydney, Australia